首页 > 最新文献

中国药理学与毒理学杂志最新文献

英文 中文
Research progress in targets and drugs for novel coronavirus 新型冠状病毒的靶点和药物研究进展
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-01-01 DOI: 10.3867/j.issn.1000-3002.2020.12.001
L. Han, T. X. Wang, Z. Xiao, Wen-xia Zhou, Yongxiang Zhang
The outbreak of coronavirus disease-19 (COVID-19) caused by novel coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) has posed a serious threat to public health. Virus particles of SARS-CoV-2 are composed of outer envelopes and inner nucleocapsids. The nonstructural and structural proteins encoded by the genome play an important role in the whole life cycle of their adsorption, penetration, uncoating, synthesis of nucleic acids and proteins, assembly and liberation. Antiviral drugs can be developed to target the virus itself or key host molecules for virus infection. So far, antibody drugs targeting spike glycoprotein S and small molecule drugs targeting RNA polymerase have shown antiviral effects. They are currently more promising candidate drugs. However, their efficacy still needs to be proved by further clinical trials, and miracle antiviral drugs have not yet appeared. Considering the virus and host targets, the combination therapy of multi-targets and multidrugs, may achieve better therapeutic effect. In this paper, the structure and life cycle of SARS-CoV-2, the research progress in potential targets and drugs were reviewed to provide useful information for the development of anti-SARS-CoV-2 drugs.
由新型冠状病毒(严重急性呼吸综合征冠状病毒-2,简称SARS-CoV-2)引起的冠状病毒病-19 (COVID-19)疫情已对公众健康构成严重威胁。SARS-CoV-2病毒颗粒由外包膜和内核衣壳组成。基因组编码的非结构蛋白和结构蛋白在整个生命周期中起着重要的作用,包括吸附、渗透、脱包、核酸和蛋白质的合成、组装和释放。抗病毒药物可以针对病毒本身或病毒感染的关键宿主分子而开发。目前,靶向刺突糖蛋白S的抗体药物和靶向RNA聚合酶的小分子药物已显示出抗病毒作用。它们是目前更有希望的候选药物。但其疗效仍需进一步的临床试验证明,目前还没有出现神奇的抗病毒药物。考虑到病毒和宿主的靶点,多靶点、多药物联合治疗,可能会取得更好的治疗效果。本文就SARS-CoV-2的结构和生命周期、潜在靶点和药物的研究进展进行综述,以期为开发抗SARS-CoV-2药物提供有益信息。
{"title":"Research progress in targets and drugs for novel coronavirus","authors":"L. Han, T. X. Wang, Z. Xiao, Wen-xia Zhou, Yongxiang Zhang","doi":"10.3867/j.issn.1000-3002.2020.12.001","DOIUrl":"https://doi.org/10.3867/j.issn.1000-3002.2020.12.001","url":null,"abstract":"The outbreak of coronavirus disease-19 (COVID-19) caused by novel coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) has posed a serious threat to public health. Virus particles of SARS-CoV-2 are composed of outer envelopes and inner nucleocapsids. The nonstructural and structural proteins encoded by the genome play an important role in the whole life cycle of their adsorption, penetration, uncoating, synthesis of nucleic acids and proteins, assembly and liberation. Antiviral drugs can be developed to target the virus itself or key host molecules for virus infection. So far, antibody drugs targeting spike glycoprotein S and small molecule drugs targeting RNA polymerase have shown antiviral effects. They are currently more promising candidate drugs. However, their efficacy still needs to be proved by further clinical trials, and miracle antiviral drugs have not yet appeared. Considering the virus and host targets, the combination therapy of multi-targets and multidrugs, may achieve better therapeutic effect. In this paper, the structure and life cycle of SARS-CoV-2, the research progress in potential targets and drugs were reviewed to provide useful information for the development of anti-SARS-CoV-2 drugs.","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"34 1","pages":"881-898"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress in role of angiotensin-converting enzyme 2 in pathogenesis and treatment of COVID-19 血管紧张素转换酶2在新冠肺炎发病及治疗中的作用研究进展
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-01-01 DOI: 10.3867/j.issn.1000-3002.2020.08.003
L. Yang, Q. He
Severe acute respiratory syndrome Coronavirus type 2 (SARS-CoV-2) infection leads to severe acute respiratory system diseases, and its clinical manifestations and pulmonary pathological features are similar to those of acute lung injury and acute respiratory distress syndrome. Angiotensin-converting enzyme (ACE) 2 was previously identified as a functional receptor for the SARS Coronavirus (SARS-CoV), but it was recently discovered that SARS-CoV-2 could also bind to ACE2 on the cell surface to infect cells, causing cytopathic and tissue immune damage. Human ACE2, a homologous of human ACE, is a new type of metallocarboxypeptidase, with many properties distinct from ACE. ACE2 plays a unique role in the renin-angiotensin system and is involved in maintaining normal lung function. Currently, no definite and effective treatment scheme has been found for patients with Coronavirus disease 2019 (COVID-19). ACE2, as a key factor in the pathological pathway of COVID-19, is of great significance in the clinical treatment of and drug development against COVID-19. © 2020 Chinese Journal of Pharmacology and Toxicology. All rights reserved.
冠状病毒2型(SARS-CoV-2)感染可导致严重的急性呼吸系统疾病,其临床表现和肺部病理特征与急性肺损伤和急性呼吸窘迫综合征相似。血管紧张素转换酶(ACE) 2之前被确定为SARS冠状病毒(SARS- cov)的功能受体,但最近发现SARS- cov -2也可以结合细胞表面的ACE2感染细胞,引起细胞病变和组织免疫损伤。ACE2是一种与ACE同源的新型金属羧肽酶,具有许多与ACE不同的特性。ACE2在肾素-血管紧张素系统中发挥着独特的作用,并参与维持正常的肺功能。目前,对2019冠状病毒病(COVID-19)患者尚无明确有效的治疗方案。ACE2作为COVID-19病理通路的关键因子,在COVID-19的临床治疗和药物开发中具有重要意义。©2020中国药理学与毒理学杂志。版权所有。
{"title":"Research progress in role of angiotensin-converting enzyme 2 in pathogenesis and treatment of COVID-19","authors":"L. Yang, Q. He","doi":"10.3867/j.issn.1000-3002.2020.08.003","DOIUrl":"https://doi.org/10.3867/j.issn.1000-3002.2020.08.003","url":null,"abstract":"Severe acute respiratory syndrome Coronavirus type 2 (SARS-CoV-2) infection leads to severe acute respiratory system diseases, and its clinical manifestations and pulmonary pathological features are similar to those of acute lung injury and acute respiratory distress syndrome. Angiotensin-converting enzyme (ACE) 2 was previously identified as a functional receptor for the SARS Coronavirus (SARS-CoV), but it was recently discovered that SARS-CoV-2 could also bind to ACE2 on the cell surface to infect cells, causing cytopathic and tissue immune damage. Human ACE2, a homologous of human ACE, is a new type of metallocarboxypeptidase, with many properties distinct from ACE. ACE2 plays a unique role in the renin-angiotensin system and is involved in maintaining normal lung function. Currently, no definite and effective treatment scheme has been found for patients with Coronavirus disease 2019 (COVID-19). ACE2, as a key factor in the pathological pathway of COVID-19, is of great significance in the clinical treatment of and drug development against COVID-19. © 2020 Chinese Journal of Pharmacology and Toxicology. All rights reserved.","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"34 1","pages":"575-583"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell transdifferentiation for neurological disorders: Research progress 神经系统疾病的细胞转分化研究进展
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01 DOI: 10.3867/J.ISSN.1000-3002.2017.11.011
Chunyan Pei, Shu Wang, Chun-li Zhang
{"title":"Cell transdifferentiation for neurological disorders: Research progress","authors":"Chunyan Pei, Shu Wang, Chun-li Zhang","doi":"10.3867/J.ISSN.1000-3002.2017.11.011","DOIUrl":"https://doi.org/10.3867/J.ISSN.1000-3002.2017.11.011","url":null,"abstract":"","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"31 1","pages":"1106-1113"},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43036514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electrophysiological changes for toxic effect of colistin sulphate on sciatic-tibial nerves in mice 硫酸粘菌素对小鼠坐骨-胫神经毒性作用的电生理变化
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2012-12-01 DOI: 10.3867/J.ISSN.1000-3002.2012.06.012
Chongshan Dai, Ji Chang Li, Wei Lin, Feng Wang, M. C. Sun, Jian Li
OBJECTIVE To investigate the toxic actions of colistin sulphate on sciatic-tibial nerves of mice.METHODS Colistin sulphate 7.5 mg·kg-1 was iv administered to Kunming female mice,twice a day.The mice were divided into colistin sulphate 1,3,7 d and 7 d post colistin sulphate groups according the adminstration for 1,3 and 7 d,respectively.The body mass and gait observations were obtained first,followed by determinations of foot splay and the threshold intensity(TI),maximal intensity(MI),compound action potential duration(CAPD),latency of compound action potential(CAPL),compound action potential amplitude(peak to peak)(CAPA),and nerve conduction velocity(NCV) of sciatic-tibial nerve.Serum creatinine(Cre) and urea nitrogen(BUN) concentrations were determined before the first dose on 2nd day(d 2),d 4,d 8 and d 15(the day of the first dose as the first day).RESULTS Compared with normal control group,after colistin sulphate was given for 1 d,Cre showed significant difference(P0.05);and for 3 d,BUN and body mass showed significant difference,respectively(P0.05);after colistin sulphate was given for 7 d,the gait and the foot splay showed significant difference(both P0.05).Compared with normal control group,after colistin sulphate was given for 1,3 and 7 d,TI increased by 60%,60% and 192%(P0.01),respectively;MI increased by 4%,13% and 100%(P0.05),respectively;CAPD increased by 15.1%,11.5% and 52.8%(P0.05),respectively;CAPL prolonged by 9.0%,9.0% and 14.6%(P0.05),respectively;CAPA decreased 0.92%,16.2% and 47.6%(P0.01),respectively;and NCV decreased by 7.6%,7.5% and 12.7%(P0.05),respectively.After 7 d of stopping administration,the gait and the foot splay had no significant differences,and all electrophysiology indexes showed a recovery tendency and only CAPA was significantly different(P0.05).CONCLUTION Nephrotoxicity is earlier than neurotoxicity on mice treated with colistin sulphate,at the same time,the progressive changes in CAP characteristics of the sciatic-tibial nerves are dependent with the time of colistin sulphate administration and abnormal CAPA has the longest duration time.
目的探讨硫酸粘菌素对小鼠坐骨-胫神经的毒性作用。方法昆明雌性小鼠静脉注射硫酸粘菌素7.5 mg·kg-1,每天2次。小鼠按给药1、3、7 d分为硫酸粘菌素后1、3、7 d组。首先进行体质量和步态观察,然后测定足张度和阈值强度(TI)、最大强度(MI)、复合动作电位持续时间(CAPD)、复合动作电位潜伏期(CAPL)、复合动作电位振幅(峰对峰)(CAPA)、坐骨胫神经神经传导速度(NCV)。测定首次给药前第2天(第2天)、第4天、第8天、第15天(第1次给药当天)血清肌酐(Cre)和尿素氮(BUN)浓度。结果与正常对照组比较,给予硫酸粘菌素1 d后,Cre差异有统计学意义(P0.05);给予硫酸粘菌素3 d后,BUN、体质量差异有统计学意义(P0.05);给予硫酸粘菌素7 d后,步态、足展度差异有统计学意义(P0.05)。与正常对照组比较,给予硫酸粘菌素1、3、7 d后,TI分别提高了60%、60%、192%(P0.01), MI分别提高了4%、13%、100%(P0.05), CAPD分别提高了15.1%、11.5%、52.8%(P0.05), CAPL分别延长了9.0%、9.0%、14.6%(P0.05), CAPA分别降低了0.92%、16.2%、47.6%(P0.01), NCV分别降低了7.6%、7.5%、12.7%(P0.05)。停药7 d后,步态和足展无显著差异,各电生理指标均有恢复趋势,仅CAPA有显著差异(P0.05)。结论硫酸粘菌素对小鼠的肾毒性早于神经毒性,同时,坐骨胫神经CAP特征的进行性改变与硫酸粘菌素给药时间有关,且CAPA异常持续时间最长。
{"title":"Electrophysiological changes for toxic effect of colistin sulphate on sciatic-tibial nerves in mice","authors":"Chongshan Dai, Ji Chang Li, Wei Lin, Feng Wang, M. C. Sun, Jian Li","doi":"10.3867/J.ISSN.1000-3002.2012.06.012","DOIUrl":"https://doi.org/10.3867/J.ISSN.1000-3002.2012.06.012","url":null,"abstract":"OBJECTIVE To investigate the toxic actions of colistin sulphate on sciatic-tibial nerves of mice.METHODS Colistin sulphate 7.5 mg·kg-1 was iv administered to Kunming female mice,twice a day.The mice were divided into colistin sulphate 1,3,7 d and 7 d post colistin sulphate groups according the adminstration for 1,3 and 7 d,respectively.The body mass and gait observations were obtained first,followed by determinations of foot splay and the threshold intensity(TI),maximal intensity(MI),compound action potential duration(CAPD),latency of compound action potential(CAPL),compound action potential amplitude(peak to peak)(CAPA),and nerve conduction velocity(NCV) of sciatic-tibial nerve.Serum creatinine(Cre) and urea nitrogen(BUN) concentrations were determined before the first dose on 2nd day(d 2),d 4,d 8 and d 15(the day of the first dose as the first day).RESULTS Compared with normal control group,after colistin sulphate was given for 1 d,Cre showed significant difference(P0.05);and for 3 d,BUN and body mass showed significant difference,respectively(P0.05);after colistin sulphate was given for 7 d,the gait and the foot splay showed significant difference(both P0.05).Compared with normal control group,after colistin sulphate was given for 1,3 and 7 d,TI increased by 60%,60% and 192%(P0.01),respectively;MI increased by 4%,13% and 100%(P0.05),respectively;CAPD increased by 15.1%,11.5% and 52.8%(P0.05),respectively;CAPL prolonged by 9.0%,9.0% and 14.6%(P0.05),respectively;CAPA decreased 0.92%,16.2% and 47.6%(P0.01),respectively;and NCV decreased by 7.6%,7.5% and 12.7%(P0.05),respectively.After 7 d of stopping administration,the gait and the foot splay had no significant differences,and all electrophysiology indexes showed a recovery tendency and only CAPA was significantly different(P0.05).CONCLUTION Nephrotoxicity is earlier than neurotoxicity on mice treated with colistin sulphate,at the same time,the progressive changes in CAP characteristics of the sciatic-tibial nerves are dependent with the time of colistin sulphate administration and abnormal CAPA has the longest duration time.","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"26 1","pages":"847-852"},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic toxicity of TAT-P53 fusion protein in mice TAT-P53融合蛋白对小鼠的肝毒性
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2012-06-01 DOI: 10.3867/J.ISSN.1000-3002.2012.03.016
Yu Zhao, Junhua Wu, Pei-yuan Jia, Shaoping Wu, Shane Gao, W. Chenyu, Y. Wang
{"title":"Hepatic toxicity of TAT-P53 fusion protein in mice","authors":"Yu Zhao, Junhua Wu, Pei-yuan Jia, Shaoping Wu, Shane Gao, W. Chenyu, Y. Wang","doi":"10.3867/J.ISSN.1000-3002.2012.03.016","DOIUrl":"https://doi.org/10.3867/J.ISSN.1000-3002.2012.03.016","url":null,"abstract":"","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"26 1","pages":"344-346"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High concentration of tacrolimus inhibits proliferation and osteoblastic differentiation of human mesenchymal stem cells 高浓度他克莫司抑制人间充质干细胞的增殖和成骨细胞分化
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2011-06-01 DOI: 10.3867/J.ISSN.1000-3002.2011.03.001
H. Wei, W. Pan, Ni Qiu, Li Huang, Hong-hao Zhou, Zhousheng Xiao
OBJECTIVE To investigate the effect of tacrolimus on cell proliferation and osteoblastic differentiation of primary human bone marrow-derived mesenchymal stem cells(hBMSCs).METHODS hBMSCs were cultured with tacrolimus 0.001-5 μmol·L-1.BrdU incorporation was used to assess the cell proliferation while cellular alkaline phosphatase(ALP) activity and calcium deposition were measured to evaluate the osteoblastic differentiation of hBMSCs cultures.The calcineurin(CaN) activity was also examined using commercial CaN assay kit,and core binding factor 1 alpha subunit(Cbfα1) protein level was determined by Western blotting.RESULTSTacrolimus 0.001-0.1 μmol·L-1 promoted BrdU incorporation but had no effect on ALP activity and calcium deposition,whereas tacrolimus 0.5-5 μmol·L-1 resulted in significant decrease in both cell proliferation and osteoblastic maturation,by reducing BrdU incorporation,ALP activity,and calcium deposition of hBMSCs cultures in a concentration-dependent manner.In addition,tacrolimus 0.5-5 μmol·L-1 led to concentration-dependent decrement in CaN activity,which was consistent with down-regulated Cbfα1 protein in the tacrolimus treated cells.CONCLUSION High concentration of tacrolimus might inhibit the cell proliferation and osteoblastic differentiation of hBMSCs cultures through a CaN/Cbfα1 pathway.
目的探讨他克莫司对人骨髓间充质干细胞(hBMSCs)细胞增殖和成骨分化的影响。方法以他克莫司0.001 ~ 5 μmol·L-1培养hBMSCs。用BrdU掺入评价细胞增殖,用碱性磷酸酶(ALP)活性和钙沉积评价hBMSCs的成骨分化。采用商业CaN检测试剂盒检测钙调神经磷酸酶(calcalineurin, CaN)活性,Western blotting检测核心结合因子1 α亚基(Cbfα1)蛋白水平。结果他克莫司0.001 ~ 0.1 μmol·L-1可促进BrdU掺入,但对ALP活性和钙沉积无影响,而他克莫司0.5 ~ 5 μmol·L-1可通过降低BrdU掺入、ALP活性和钙沉积而显著降低hBMSCs培养物的增殖和成骨细胞成熟,并呈浓度依赖性。此外,他克莫司0.5 ~ 5 μmol·L-1可导致CaN活性呈浓度依赖性下降,这与他克莫司处理后细胞中Cbfα1蛋白表达下调一致。结论高浓度他克莫司可能通过CaN/Cbfα1通路抑制hBMSCs的增殖和成骨分化。
{"title":"High concentration of tacrolimus inhibits proliferation and osteoblastic differentiation of human mesenchymal stem cells","authors":"H. Wei, W. Pan, Ni Qiu, Li Huang, Hong-hao Zhou, Zhousheng Xiao","doi":"10.3867/J.ISSN.1000-3002.2011.03.001","DOIUrl":"https://doi.org/10.3867/J.ISSN.1000-3002.2011.03.001","url":null,"abstract":"OBJECTIVE To investigate the effect of tacrolimus on cell proliferation and osteoblastic differentiation of primary human bone marrow-derived mesenchymal stem cells(hBMSCs).METHODS hBMSCs were cultured with tacrolimus 0.001-5 μmol·L-1.BrdU incorporation was used to assess the cell proliferation while cellular alkaline phosphatase(ALP) activity and calcium deposition were measured to evaluate the osteoblastic differentiation of hBMSCs cultures.The calcineurin(CaN) activity was also examined using commercial CaN assay kit,and core binding factor 1 alpha subunit(Cbfα1) protein level was determined by Western blotting.RESULTSTacrolimus 0.001-0.1 μmol·L-1 promoted BrdU incorporation but had no effect on ALP activity and calcium deposition,whereas tacrolimus 0.5-5 μmol·L-1 resulted in significant decrease in both cell proliferation and osteoblastic maturation,by reducing BrdU incorporation,ALP activity,and calcium deposition of hBMSCs cultures in a concentration-dependent manner.In addition,tacrolimus 0.5-5 μmol·L-1 led to concentration-dependent decrement in CaN activity,which was consistent with down-regulated Cbfα1 protein in the tacrolimus treated cells.CONCLUSION High concentration of tacrolimus might inhibit the cell proliferation and osteoblastic differentiation of hBMSCs cultures through a CaN/Cbfα1 pathway.","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"25 1","pages":"223-228"},"PeriodicalIF":0.0,"publicationDate":"2011-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of organic anion transporters in xenobiotics induced toxicity 有机阴离子转运体在外源性药物诱导毒性中的作用
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2009-06-01 DOI: 10.3867/J.ISSN.1000-3002.2009.03.013
X. Xue, Li-kun Gong, Jin Ren
It is unavoidable for body to exposure of organic anions including endogenous agents such as hormones,neurotransmitters and cellular metabolites,and xenobiotic agents such as medication,herbicides,pesticides,and plant and animal toxins. Rapid and efficient elimination of toxic substances among them is the body′s best defense. The active transepithelial transport mediated by organic anion transporters is often a rate-limiting step. Therefore,the investigations of organic anion transporters about their classification,tissue distrubution driving force,gene expression and regulatory are of great significance in toxicology.
人体不可避免地会接触到有机阴离子,包括内源性物质,如激素、神经递质和细胞代谢物,以及外源性物质,如药物、除草剂、杀虫剂和动植物毒素。快速有效地清除其中的有毒物质是人体最好的防御。由有机阴离子转运体介导的活性上皮转运通常是一个限速步骤。因此,研究有机阴离子转运体的分类、组织分布、驱动力、基因表达和调控等在毒理学研究中具有重要意义。
{"title":"Role of organic anion transporters in xenobiotics induced toxicity","authors":"X. Xue, Li-kun Gong, Jin Ren","doi":"10.3867/J.ISSN.1000-3002.2009.03.013","DOIUrl":"https://doi.org/10.3867/J.ISSN.1000-3002.2009.03.013","url":null,"abstract":"It is unavoidable for body to exposure of organic anions including endogenous agents such as hormones,neurotransmitters and cellular metabolites,and xenobiotic agents such as medication,herbicides,pesticides,and plant and animal toxins. Rapid and efficient elimination of toxic substances among them is the body′s best defense. The active transepithelial transport mediated by organic anion transporters is often a rate-limiting step. Therefore,the investigations of organic anion transporters about their classification,tissue distrubution driving force,gene expression and regulatory are of great significance in toxicology.","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"23 1","pages":"237-240"},"PeriodicalIF":0.0,"publicationDate":"2009-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effect of recombinant bovine pancreatic trypsin inhibitor on chronic liver injury induced by carbon tetrachloride in rats 重组牛胰蛋白酶抑制剂对四氯化碳所致大鼠慢性肝损伤的保护作用
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2008-06-01 DOI: 10.3867/J.ISSN.1000-3002.2008.03.007
L. Yang, J. He, Wen Dong, Xin Zhang, C. Zhou, X. Ren, Weiqun Yan
AIM To observe the protection of recombinant bovine pancreatic trypsin inhibitor(rBPTI) against chronic liver injury.METHODS Ninety eight rats were randomized into 7 groups:normal control,model control,rBPTI 20,40 and 80 MU·kg-1,aprotinin 80 MU·kg-1 and hepatocyte growth-promoting factor(pHGF) 100 mg·kg-1 groups.The chronic liver injury rat model was induced by carbon tetrachloride(CCl4).After 8 weeks,the rats were administered(ip) with rBPTI,aprotinin or pHGF daily for 4 weeks except that in normal and model control groups.The glutamic-pyruvic transaminase(GPT) and glutamic-oxalacetic transaminase(GOT) activities,albumin(Alb) content,Alb and globulin content ratio(A/G),sialic acid(SA) content in serum were measured.Hydroxyproline(Hyp) level and histopathological changes of hepatic tissue were also examined.RESULTS Compared with normal control group,the activities of serum GPT and GOT,and the contents of SA in serum and Hyp in liver tissue in model group were increased,and the content of serum Alb and A/G ratio were decreased.Compared with model group,rBPTI(20,40 and 80 MU·kg-1) decreased the activities of GPT and GOT,and the contents of SA in serum and Hyp in liver tissue.The content of serum Alb and A/G ratio were increased by rBPTI.In addition,rBPTI alleviated chronic hepatic injuries such as fatty degeneration and liver fibrosis significantly.CONCLUSION rBPTI has protective and anti-fibrosis effects against chronic liver injury induced by CCl4,and the efficiency is equivalent as aprotinin in the observed dosages.
目的观察重组牛胰蛋白酶抑制剂(rBPTI)对慢性肝损伤的保护作用。方法98只大鼠随机分为正常对照组、模型对照组、rBPTI 20、40、80 MU·kg-1组、抑肽蛋白80 MU·kg-1组和肝细胞生长促进因子(pHGF) 100 mg·kg-1组。采用四氯化碳(CCl4)诱导大鼠慢性肝损伤模型。8周后,除正常组和模型对照组外,每天给予rBPTI、抑蛋白素或pHGF (ip),连续4周。测定大鼠血清中谷丙转氨酶(GPT)、谷草转氨酶(GOT)活性、白蛋白(Alb)含量、白蛋白与球蛋白含量比(A/G)、唾液酸(SA)含量、羟脯氨酸(Hyp)水平及肝组织病理变化。结果与正常对照组比较,模型组大鼠血清GPT、GOT活性升高,血清SA和肝组织Hyp含量升高,血清Alb含量和A/G比值降低。与模型组比较,rBPTI(20、40、80 MU·kg-1)可降低血清GPT、GOT活性,降低血清SA含量,降低肝组织Hyp含量。rBPTI可提高血清白蛋白含量和A/G比值。rBPTI对慢性肝损伤如脂肪变性、肝纤维化有明显的缓解作用。结论rBPTI对CCl4诱导的慢性肝损伤具有保护和抗纤维化作用,且在观察剂量下其作用与抑酶蛋白相当。
{"title":"Protective effect of recombinant bovine pancreatic trypsin inhibitor on chronic liver injury induced by carbon tetrachloride in rats","authors":"L. Yang, J. He, Wen Dong, Xin Zhang, C. Zhou, X. Ren, Weiqun Yan","doi":"10.3867/J.ISSN.1000-3002.2008.03.007","DOIUrl":"https://doi.org/10.3867/J.ISSN.1000-3002.2008.03.007","url":null,"abstract":"AIM To observe the protection of recombinant bovine pancreatic trypsin inhibitor(rBPTI) against chronic liver injury.METHODS Ninety eight rats were randomized into 7 groups:normal control,model control,rBPTI 20,40 and 80 MU·kg-1,aprotinin 80 MU·kg-1 and hepatocyte growth-promoting factor(pHGF) 100 mg·kg-1 groups.The chronic liver injury rat model was induced by carbon tetrachloride(CCl4).After 8 weeks,the rats were administered(ip) with rBPTI,aprotinin or pHGF daily for 4 weeks except that in normal and model control groups.The glutamic-pyruvic transaminase(GPT) and glutamic-oxalacetic transaminase(GOT) activities,albumin(Alb) content,Alb and globulin content ratio(A/G),sialic acid(SA) content in serum were measured.Hydroxyproline(Hyp) level and histopathological changes of hepatic tissue were also examined.RESULTS Compared with normal control group,the activities of serum GPT and GOT,and the contents of SA in serum and Hyp in liver tissue in model group were increased,and the content of serum Alb and A/G ratio were decreased.Compared with model group,rBPTI(20,40 and 80 MU·kg-1) decreased the activities of GPT and GOT,and the contents of SA in serum and Hyp in liver tissue.The content of serum Alb and A/G ratio were increased by rBPTI.In addition,rBPTI alleviated chronic hepatic injuries such as fatty degeneration and liver fibrosis significantly.CONCLUSION rBPTI has protective and anti-fibrosis effects against chronic liver injury induced by CCl4,and the efficiency is equivalent as aprotinin in the observed dosages.","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"22 1","pages":"193-198"},"PeriodicalIF":0.0,"publicationDate":"2008-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of cryopreservation on metabolic activities of hepatocytes 低温保存对肝细胞代谢活性的影响
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2008-01-01 DOI: 10.3867/J.ISSN.1000-3002.2008.06.011
Q. Pan, Y. Chen, L. Mei, R. Dai
AIM To study the effect of cryopreservation on metabolic activities and cytochrome P450(CYP) mRNA expression in hepatocytes and provide support for application of cryopreserved hepatocytes in experimental research.METHODS Freshly isolated rat hepatocytes were cryopreserved with rate-controlled freezer,and thawed after 1 month.Real-time quantitative PCR was used to detect expressions of CYP1A2,CYP2B1 and CYP3A1 mRNA,and LC-MS/MS was used to measure contents of metabolites of midazolam-1′-hydrxylation(OH-Mid),diclofenac-4′-hydroxylation(OH-Dic) and dextromethorphan-O-demethylation(Dex) in hepatocytes,respectively.RESULTS There was no significant difference in cell viability between fresh and cryopreserved hepatocytes.The cryopreserved hepatocytes attached and established extensive cell-cell contact,with round and bright nucleus.CYP1A2 and CYP2B1 mRNA expressions induced by β-naphthoflavone and phenobarbital in cryopreserved hepatocytes were similar to that in the fresh primary cells.However,CYP3A1 mRNA expression did not induced by pregnenolone-16α-carbonitrile in cryopreserved hepatocytes.In cryopreserved hepatocytes,the content of OH-Mid was remained as almost the same as the fresh primary hepatocytes,while contents of OH-Dic decreased approximately as a half,and Dex was double as fresh hepatocytes.CONCLUSION Cryopreservation exerts different effects on metabolic activities of hepatocytes.To acquire objective and appropriate results,it is necessary to consider the different influence of cryopreservation on cell metabolic activity in drug metabolic research.
目的研究低温保存对肝细胞代谢活性及细胞色素P450(CYP) mRNA表达的影响,为低温保存肝细胞在实验研究中的应用提供支持。方法新鲜分离的大鼠肝细胞采用速控冷冻机冷冻保存,1个月后解冻。Real-time定量PCR检测CYP1A2、CYP2B1和CYP3A1 mRNA的表达,LC-MS/MS检测肝细胞中咪达唑仑-1′-羟基化(OH-Mid)、双氯芬酸-4′-羟基化(OH-Dic)和右美沙芬- o -去甲基化(Dex)代谢物的含量。结果新鲜肝细胞和冷冻肝细胞的细胞活力无显著差异。冷冻保存的肝细胞附着并建立了广泛的细胞间接触,细胞核圆而明亮。β-萘黄酮和苯巴比妥对低温保存肝细胞中CYP1A2和CYP2B1 mRNA表达的影响与新鲜原代细胞相似。而孕烯醇酮-16α-碳腈在低温保存的肝细胞中没有诱导CYP3A1 mRNA的表达。在冷冻保存的肝细胞中,OH-Mid的含量与新鲜原代肝细胞几乎相同,OH-Dic的含量减少了大约一半,Dex的含量是新鲜肝细胞的两倍。结论低温保存对肝细胞代谢活性有不同的影响。在药物代谢研究中,为了获得客观合理的结果,需要考虑低温保存对细胞代谢活性的不同影响。
{"title":"Effect of cryopreservation on metabolic activities of hepatocytes","authors":"Q. Pan, Y. Chen, L. Mei, R. Dai","doi":"10.3867/J.ISSN.1000-3002.2008.06.011","DOIUrl":"https://doi.org/10.3867/J.ISSN.1000-3002.2008.06.011","url":null,"abstract":"AIM To study the effect of cryopreservation on metabolic activities and cytochrome P450(CYP) mRNA expression in hepatocytes and provide support for application of cryopreserved hepatocytes in experimental research.METHODS Freshly isolated rat hepatocytes were cryopreserved with rate-controlled freezer,and thawed after 1 month.Real-time quantitative PCR was used to detect expressions of CYP1A2,CYP2B1 and CYP3A1 mRNA,and LC-MS/MS was used to measure contents of metabolites of midazolam-1′-hydrxylation(OH-Mid),diclofenac-4′-hydroxylation(OH-Dic) and dextromethorphan-O-demethylation(Dex) in hepatocytes,respectively.RESULTS There was no significant difference in cell viability between fresh and cryopreserved hepatocytes.The cryopreserved hepatocytes attached and established extensive cell-cell contact,with round and bright nucleus.CYP1A2 and CYP2B1 mRNA expressions induced by β-naphthoflavone and phenobarbital in cryopreserved hepatocytes were similar to that in the fresh primary cells.However,CYP3A1 mRNA expression did not induced by pregnenolone-16α-carbonitrile in cryopreserved hepatocytes.In cryopreserved hepatocytes,the content of OH-Mid was remained as almost the same as the fresh primary hepatocytes,while contents of OH-Dic decreased approximately as a half,and Dex was double as fresh hepatocytes.CONCLUSION Cryopreservation exerts different effects on metabolic activities of hepatocytes.To acquire objective and appropriate results,it is necessary to consider the different influence of cryopreservation on cell metabolic activity in drug metabolic research.","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70223320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrial natriuretic factor decreases circulating blood volume in nephrectomized rats 心房利钠因子降低肾切除大鼠循环血容量
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 1993-01-01 DOI: 10.1016/0022-2828(92)90671-l
Zhang Yu
{"title":"Atrial natriuretic factor decreases circulating blood volume in nephrectomized rats","authors":"Zhang Yu","doi":"10.1016/0022-2828(92)90671-l","DOIUrl":"https://doi.org/10.1016/0022-2828(92)90671-l","url":null,"abstract":"","PeriodicalId":10149,"journal":{"name":"Chinese Journal of Pharmacology and Toxicology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0022-2828(92)90671-l","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53169955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国药理学与毒理学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1